-transparent.png){kind=logo}
A semi-synthetic bleomycin analogue and its DNA binding moiety, an alkylamino-2-methoxy-6-chloroacridine, have been found to inhibit human immunodeficiency virus-associated reverse transcriptase. The authors have synthesized various new alkylaminoacridine derivatives. Alkylaminoacridines with basic functional groups showed the enzyme inhibitory activity with less cytotoxicity.
Related Publications
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
April 1989,
The Journal of antibiotics,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
September 1990,
European journal of biochemistry,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
January 1990,
Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College = Chung-kuo i hsueh k'o hsueh yuan, Chung-kuo hsieh ho i k'o ta hsueh hsueh pao,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
April 1989,
The Journal of biological chemistry,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
April 1995,
The Biochemical journal,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
August 1987,
The Journal of general virology,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
June 2006,
Biochemistry,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
July 1991,
Proceedings of the National Academy of Sciences of the United States of America,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
July 2014,
Antimicrobial agents and chemotherapy,
S Atsumi, and
Y Muraoka, and
T Nogami, and
H Hoshino, and
T Takeuchi, and
K Umezawa
October 2003,
Journal of medicinal chemistry,
